Targeting DORIS Remission and LLDAS in SLE: A Review

Remission is the established therapeutic goal for patients with systemic lupus erythematosus (SLE) and is currently defined by the widely adopted Definition Of Remission In SLE (DORIS) criteria. Attainment of remission is rare in the clinical setting, thus an alternative, pragmatic treatment target...

Descripción completa

Detalles Bibliográficos
Autores principales: Parra Sánchez, Agner R., van Vollenhoven, Ronald F., Morand, Eric F., Bruce, Ian N., Kandane-Rathnayake, Rangi, Weiss, Gudrun, Tummala, Raj, Al-Mossawi, Hussein, Sorrentino, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654283/
https://www.ncbi.nlm.nih.gov/pubmed/37798595
http://dx.doi.org/10.1007/s40744-023-00601-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654283/
https://www.ncbi.nlm.nih.gov/pubmed/37798595
http://dx.doi.org/10.1007/s40744-023-00601-w

Ejemplares similares